These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Monoclonal antibodies targeting VEGF in ophthalmology: the case of exudative age-related macular degeneration].
    Author: Leveziel N, Soubrane G, Souied EH.
    Journal: Med Sci (Paris); 2009 Dec; 25(12):1105-7. PubMed ID: 20035686.
    Abstract:
    Age-related macular degeneration (AMD) is the main cause of vision loss in the elderly in developed countries. The exudative AMD is the most frequent and severe form of the disease, leading to a rapid loss of vision. The results of MARINA and ANCHOR studies, two multicentric clinical trials analyzing the efficacy of anti-VEGF in exudative AMD, have showed that this modality of treatment results in a stabilisation of the visual acuity in most cases (70%), and in visual improvement in 30 % of the cases. Up till now, the anti-VEGF approach represents a major step in the therapeutic strategy of this disease.
    [Abstract] [Full Text] [Related] [New Search]